STOCK TITAN

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Schrödinger (SDGR) will release its Q4 and full-year 2023 financial results on February 28, 2024, after market close. A conference call and webcast will follow at 4:30 p.m. ET, accessible on the company's website.
Positive
  • None.
Negative
  • None.

NEW YORK--(BUSINESS WIRE)-- Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its fourth quarter and full-year 2023 financial results on Wednesday, February 28, 2024, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.

Allie Nicodemo

Schrödinger, Inc.

allie.nicodemo@schrodinger.com

617-356-2325

Source: Schrödinger

Schrödinger (SDGR) will report its Q4 and full-year 2023 financial results on Wednesday, February 28, 2024, after the financial markets close.

The conference call and webcast for Schrödinger (SDGR) will be at 4:30 p.m. ET.

Investors can access the live webcast in the 'Investors' section of Schrödinger's website.

The webcast will be archived for approximately 90 days following the event for Schrödinger (SDGR).
Schrodinger Inc

NASDAQ:SDGR

SDGR Rankings

SDGR Latest News

SDGR Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Technology Services, Packaged Software, Manufacturing, Pharmaceutical Preparation Manufacturing
US
New York

About SDGR

schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. the predictive power of schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries that might otherwise not be possible. schrödinger also establishes deep partnerships and collaborations with companies in such fields as biotechnology, pharmaceuticals, chemicals, and electronics, and helped found the biotech company nimbus therapeutics. through significant long-term investments in basic research, schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. hundreds of peer-reviewed scientific publications by schrödinger scientists are frequently among the most heavily cited in their fields. founded in 1990, schrödinger has operations in the us, europe, japan, and india, with business part